A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 2887553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticholinergic effects on memory: benztropine vs. amantadine.

  1987cited by this paper
• Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.

  1987cited by this paper
• Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.

  1987cited by this paper
• Age-impaired impulse flow from nucleus basalis to cortex

  1985cited by this paper
• Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study

  1984cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients

  1983cited by this paper
• Anti-Cholinergic Drugs and Memory

  1983cited by this paper
• Effects of anticholinergic drugs on memory in Parkinson's disease.

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

  1982cited by this paper
• Anti-Cholinergic Drugs and Memory: the Effects of Benzhexol on Memory in a Group of Geriatric Patients

  1982cited by this paper
• Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients.

  1981cited by this paper
• Memory and cognitive function in man

  1977cited by this paper
• Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.

  1976cited by this paper
• A controlled trial of amantadine in drug-induced extrapyramidal disorders.

  1976cited by this paper
• Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.

  1976cited by this paper
• A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.

  1974cited by this paper
• The central effects of scopolamine in man.

  1971cited by this paper
• Medical therapy of Parkinsonism.

  1968cited by this paper
• Central nervous system effects of hyoscine in man.

  1962cited by this paper
• The effects of atropine on the electroencephalogram and behavior in man.

  1960cited by this paper

• Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.

  2022cites this paper
• Revisiting Amantadine as A Treatment for Drug-Induced Movement Disorders

  2020cites this paper
• The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder.

  2019cites this paper
• Emergency Management of Acute Psychosis

  2019cites this paper
• Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders.

  2019cites this paper
• Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia

  2017cites this paper
• Zwickmühle: Medikation bei Demenz

  2016cites this paper
• The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: A preliminary open-label trial

  2014cites this paper
• Benefits and limits of anticholinergic use in schizophrenia: Focusing on its effect on cognitive function

  2014cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Fluphenazine (oral) versus placebo for schizophrenia.

  2013cites this paper
• First-Episode Schizophrenia

  2012cites this paper
• Pharmacological Management of Acute Agitation

  2012cites this paper
• The influence of switching from haloperidol decanoate depot to risperidone long‐acting injection on the clinical symptoms and cognitive function in schizophrenia

  2012cites this paper
• [Usage of drugs with potential adverse effects on cognition in a memory-clinic].

  2009cites this paper
• Intramuscular Haloperidol versus Intramuscular Olanzapine for Treatment of Acute Agitation: A Cost‐Minimization Study

  2009cites this paper
• Providing care closer to home

  2007cites this paper
• Pharmakotherapie der Schizophrenie

  2006cites this paper
• Effectiveness of quetiapine for the management of aggressive psychosis in the emergency psychiatric setting: a naturalistic uncontrolled trial

  2005cites this paper
• Depression in schizophrenia: Current guidelines to treatment

  2005cites this paper
• Dose Response and Dose Equivalence of Antipsychotics

  2004cites this paper
• Pharmacological management of agitation in emergency settings

  2003cites this paper
• RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.

  2003cites this paper
• Long-term results of renal transplantation using kidneys harvested from non-heartbeating donors: a 15-year experience.

  2003cites this paper
• Therapeutic Efficacy Of Extended Release Oxybutynin Chloride, And Immediate Release And Long Acting Tolterodine Tartrate In Children With Diurnal Urinary Incontinence

  2003cites this paper
• Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

  2002cites this paper
• Effects of risperidone on information processing and attention in first-episode schizophrenia.

  2002cites this paper
• Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum

  2002cites this paper
• Comparison of Risperidone with Olanzapine in Elderly Patients with Dementia and Psychosis

  2002cites this paper
• Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

  2001cites this paper
• Management of Acute Psychosis in the Emergency Setting

  2000cites this paper
• Die Anwendung von Clozapin bei akuten manischen Syndromen

  1999cites this paper
• Cognitive side effects of medications.

  1998cites this paper
• Reversible memory disturbance and intelligence impairment induced by long-term anticholinergic therapy.

  1998cites this paper
• Anticholinergic drugs and cognitive functions.

  1998cites this paper
• Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?

  1998cites this paper
• Stellenwert und Grenzen klassischer und neuer Neuroleptika in der Therapie von Erregungszuständen und manischen Syndromen

  1998cites this paper
• Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

  1997cites this paper
• Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons.

  1997cites this paper
• Two rapid-dose titrations of sertindole in patients with schizophrenia.

  1997cites this paper
• Management of acute extrapyramidal effects induced by antipsychotic drugs.

  1997cites this paper
• Management of Acute Antipsychotic-Induced Extrapyramidal Syndromes

  1996cites this paper
• The role of cognition in the risk‐benefit and safety analysis of antipsychotic medication

  1996cites this paper
• On Prescribing an Antiparkinsonian Drug

  1996cites this paper
• Minimizing the non‐extrapyramidal side‐effects of antipsychotics

  1996cites this paper
• Amantadine does not exacerbate positive symptoms in medicated, chronic schizophrenic patients: evidence from a double-blind crossover study.

  1996cites this paper
• No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.

  1995cites this paper
• Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy.

  1995cites this paper
• Dosing Issues: Target Symptoms and Dose Response

  1995cites this paper
• Effects of Biperiden and Amantadine on Memory in Medicated Chronic Schizophrenic Patients

  1995cites this paper
• Antipsychotic drug use in older adults.

  1994cites this paper
• Treatment of Acute Neuroleptic‐Induced Movement Disorders

  1994cites this paper
• Adjunctive Medication in the Maintenance Treatment of Schizophrenia and its Conceptual Implications

  1993cites this paper
• Adjunctive Medication in the Maintenance Treatment of Schizophrenia and its Conceptual Implications

  1993cites this paper
• Prediction of social skill acquisition in schizophrenic and major affective disorder patients from memory and symptomatology.

  1991cites this paper
• Pharmacological treatment of substance-abusing schizophrenic patients.

  1990cites this paper
• A review of clozapine: an antipsychotic for treatment-resistant schizophrenia.

  1990cites this paper
• Early Diagnosis and Preventive Therapy in Parkinson’s Disease

  1989cites this paper
• Over-the-Counter (OTC) Drugs and Some Prescription Drugs

  1989cites this paper
• Clinical pharmacology of amantadine and derivatives

  1989cites this paper
• Drug-related cognitive impairment: current progress and recurrent problems.

  1989cites this paper
• Rapid tranquilization of the violent patient.

  1989cites this paper
• Pharmacokinetics of neuroleptic drugs and the utility of plasma level monitoring.

  1988cites this paper
• Review Article: Psychopharmacologic Treatment in Neurological Practice

  1987cites this paper